CTA News

CTA News2020-03-15T11:08:35+00:00

CTA’s Developmental Therapeutics Update Dinner Series draws to a close for the second year

December 1st, 2023|

In late November CTA was pleased to host our second Developmental Therapeutics Update Dinner meeting for 2023, presented with the generous support of the Series sponsors, namely Amgen, AstraZeneca, [...]

10,000th Australian patient accrued by ground-breaking cancer trials collaborative

October 20th, 2020|

In a major milestone for Australian cancer patients, the not-for-profit, member-based organisation, Cancer Trials Australia (CTA), has recently marked the recruitment of the 10,000th oncology patient to clinical trials [...]

CTA CEO discusses key considerations for Chinese biotechs considering conducting clinical trials in Australia

November 15th, 2019|

Cancer Trials Australia’s CEO, Dr. Kurt Lackovic, was a panelist at the 12th annual ‘China Trials – Clinical Development Leaders’ summit’ in Shanghai this week.  Other panelists included Jayden [...]

CTA announces partnership to drive Teletrials forward at Victorian study sites

November 11th, 2019|

Cancer Trials Australia (CTA) is pleased to announce a new project, to be delivered with the Victorian Comprehensive Cancer Centre (VCCC), providing Victorian sites with an exciting opportunity to [...]

CTA CEO presents at 3rd Annual Accelerating Clinical Trials in Asia conference

September 26th, 2019|

By 2021, the global market for clinical trials is anticipated to grow to $60Bn, a 75% increase over 2015. The largest contributor to this huge growth is the Asia-Pacific region.Cancer [...]

Coordinated Electronic Document Management for Victorian study sites

November 22nd, 2018|

CTA announces partnership in delivering coordinated Electronic Document Management for Victorian study sites Cancer Trials Australia (CTA) is pleased to announce a new project funded by the Victorian Comprehensive [...]

Go to Top